DNMT3A and hepatocellular carcinoma: circSOD2 expression enhanced cancer cell growth, cell migration, cell cycle progression, and in vivo tumor growth in hepatocellular cancer; circSOD2 inhibited miR-502-5p expression, thereby upregulating DNMT3A expression [24].